99 related articles for article (PubMed ID: 21961284)
1. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. II. The role of interleukin-2].
Shatrova AN; Zenin VV; Aksenov ND; Mitiushova EV; Marakhova II
Tsitologiia; 2011; 53(8):652-8. PubMed ID: 21961284
[TBL] [Abstract][Full Text] [Related]
2. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. I. The role of JAK and Src tyrosine kinases as revealed by inhibitory analysis].
Zenin VV; Aksenov ND; Shatrova AN; Mitiushova EV; Marakhova II
Tsitologiia; 2011; 53(8):645-51. PubMed ID: 21961283
[TBL] [Abstract][Full Text] [Related]
3. [The expression of CD25 in phytohemagglutinin- or interleukin-2-stimulated human peripheral blood lymphocytes].
Zenin VV; Aksenov ND; Shatrova AN; Marakhova II
Tsitologiia; 2009; 51(6):506-10. PubMed ID: 19637754
[TBL] [Abstract][Full Text] [Related]
4. [THE INDUCTION OF CD25 EXPRESSION IN Jurkat T CELLS].
Shatrova AN; Mityushova EV; Aksenov NV; Marakhova LL
Tsitologiia; 2015; 57(5):345-52. PubMed ID: 26281211
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.
Shatrova AN; Mityushova EV; Vassilieva IO; Aksenov ND; Zenin VV; Nikolsky NN; Marakhova II
PLoS One; 2016; 11(12):e0167215. PubMed ID: 27936140
[TBL] [Abstract][Full Text] [Related]
7. [The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes].
Mitiushova EV; Shatrova AN; Zenin VV; Aksenov ND; Marakhova II
Tsitologiia; 2013; 55(6):421-9. PubMed ID: 25509109
[TBL] [Abstract][Full Text] [Related]
8. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
[TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
10. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW
Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863
[TBL] [Abstract][Full Text] [Related]
11. [Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli].
Karitskaia IA; Aksenov ND; Zenin VV; Khaĭdukova AL; Marakhova II
Tsitologiia; 2006; 48(1):42-9. PubMed ID: 16568834
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
Conrad DM; Hanniman EA; Watson CL; Mader JS; Hoskin DW
J Cell Biochem; 2004 May; 92(2):387-99. PubMed ID: 15108363
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
Katzen D; Chu E; Terhost C; Leung DY; Gesner M; Miller RA; Geha RS
J Immunol; 1985 Sep; 135(3):1840-5. PubMed ID: 3926887
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of resting human gamma delta T lymphocytes by interleukin-2.
Kjeldsen-Kragh J; Quayle AJ; Skålhegg BS; Sioud M; Førre O
Eur J Immunol; 1993 Sep; 23(9):2092-9. PubMed ID: 8370391
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of human lymphocyte proliferative response to purified protein derivative by an anti-interleukin-2 receptor alpha chain antibody (CD25).
Kasinrerk W; Majdic O; Praputpittaya K; Sittisombut N
Immunology; 1994 Sep; 83(1):33-7. PubMed ID: 7821963
[TBL] [Abstract][Full Text] [Related]
16. Tec protein tyrosine kinase inhibits CD25 expression in human T-lymphocyte.
Susaki K; Kitanaka A; Dobashi H; Kubota Y; Kittaka K; Kameda T; Yamaoka G; Mano H; Mihara K; Ishida T
Immunol Lett; 2010 Jan; 127(2):135-42. PubMed ID: 19883687
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes.
Xu L; Liu Y; He X
Cell Mol Immunol; 2005 Aug; 2(4):295-300. PubMed ID: 16274628
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
Rapecki S; Allen R
J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
[TBL] [Abstract][Full Text] [Related]
19. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]